Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Farringer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Drug Monitoring|January 1, 1989
Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimatesS D McClellan, J A Farringer
Clinical Pharmacy|January 1, 1984
Cimetidine--quinidine interactionJ A Farringer, K McWay-Hess, W A Clementi
Clinical Pharmacy|September 1, 1988
Predicting need for pharmacokinetic consultation follow-up using discriminant analysisD E Beck, E L Bradley, J A Farringer
Clinical Pharmacy|November 1, 1987
Accuracy of three methods for predicting concentrations of free phenytoinD E Beck, J A Farringer, W R Ravis, et al.
American Heart Journal|December 1, 1984
Nifedipine-induced alterations in serum quinidine concentrationsJ A Farringer, J A Green, R A O'Rourke, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1986
Experience with intrainstitutional clinical evaluations of newly marketed preparations as a basis for drug-product selection to hospital formulariesJ A Green, W A Clementi, M G Bufton, et al.
Therapeutic Drug Monitoring|January 1, 1988
Clinical assessment of a two-compartment Bayesian forecasting method for lidocaineC L Beach, J A Farringer, C C Peck, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|January 1, 1989
Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimatesS D McClellan, J A Farringer
Clinical Pharmacy|January 1, 1984
Cimetidine--quinidine interactionJ A Farringer, K McWay-Hess, W A Clementi
Clinical Pharmacy|September 1, 1988
Predicting need for pharmacokinetic consultation follow-up using discriminant analysisD E Beck, E L Bradley, J A Farringer
Clinical Pharmacy|November 1, 1987
Accuracy of three methods for predicting concentrations of free phenytoinD E Beck, J A Farringer, W R Ravis, et al.
American Heart Journal|December 1, 1984
Nifedipine-induced alterations in serum quinidine concentrationsJ A Farringer, J A Green, R A O'Rourke, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1986
Experience with intrainstitutional clinical evaluations of newly marketed preparations as a basis for drug-product selection to hospital formulariesJ A Green, W A Clementi, M G Bufton, et al.
Therapeutic Drug Monitoring|January 1, 1988
Clinical assessment of a two-compartment Bayesian forecasting method for lidocaineC L Beach, J A Farringer, C C Peck, et al.
Pageof 1